Prevention of antibiotic-associated metabolic syndrome in mice by intestinal alkaline phosphatase.
Prevention of antibiotic-associated metabolic syndrome in mice by intestinal alkaline phosphatase.
复制标题
通过肠道碱性磷酸酶预防小鼠中与抗生素相关的代谢综合征。
DOI:
10.1111/dom.12645
复制
发表时间:
2016-05
期刊:
影响因子:
--
通讯作者:
Hodin RA
中科院分区:
文献类型:
--
作者:
Economopoulos KP;Ward NL;Phillips CD;Teshager A;Patel P;Mohamed MM;Hakimian S;Cox SB;Ahmed R;Moaven O;Kaliannan K;Alam SN;Haller JF;Goldstein AM;Bhan AK;Malo MS;Hodin RA
Early childhood exposure to antibiotics has been implicated in the pathogenesis of metabolic syndrome (MetS) later on in adulthood. Intestinal alkaline phosphatase (IAP) preserves the normal homeostasis of intestinal microbiota and restores the normal microbiota upon cessation of antibiotic treatment. We aim to examine whether co-administration of IAP with antibiotics early in life may have a preventive role against MetS in mice. Fifty mice were allocated to four treatment groups after weaning. Mice were treated with azithromycin±IAP, or with no azithromycin±IAP, for three intermittent 7-day cycles. After the last treatment course, the mice were administered regular chow diet for five weeks and subsequently high-fat diet for five weeks. Animal body weight, food intake, water intake, serum lipids, glucose levels and liver lipids were compared. 16S rRNA gene pyrosequencing was used to determine differences in microbiome composition. Azithromycin exposure early in life rendered mice susceptible to MetS in adulthood. Co-administration of IAP with azithromycin completely prevented this susceptibility by decreasing total body weight, serum lipids, glucose levels and liver lipids to the levels of control mice. These effects of IAP likely occur due to changes in the composition of specific bacterial taxa at the genus and species levels (e.g. members of Anaeroplasma and Parabacteroides). Co-administration of IAP with azithromycin early in life prevents mice from susceptibility to the later development of MetS. This effect is associated with alterations in the composition of the gut microbiota. IAP may represent a novel treatment against MetS in humans.
登录
查看更多内容
DOI:
10.1038/ismej.2014.45
发表时间:
2014-10
期刊:
The ISME journal
影响因子:
--
作者:
通讯作者:
--
影响因子:
30.3
作者:
Bates, Jennifer M.;Akerlund, Janie;Guillemin, Karen
通讯作者:
Guillemin, Karen
影响因子:
8
作者:
Hersh, Adam L.;Shapiro, Daniel J.;Shah, Samir S.
通讯作者:
Shah, Samir S.
影响因子:
4.9
作者:
Ajslev, T. A.;Andersen, C. S.;Jess, T.
通讯作者:
Jess, T.
影响因子:
64.5
作者:
Cox LM;Yamanishi S;Sohn J;Alekseyenko AV;Leung JM;Cho I;Kim SG;Li H;Gao Z;Mahana D;Zárate Rodriguez JG;Rogers AB;Robine N;Loke P;Blaser MJ
通讯作者:
Blaser MJ